Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

A Phase III, Randomized, Double-Blind Trial to Evaluate Efficacy and Safety of Isavuconazole Versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Hematopoietic Stem Cell Transplant Patients with Invasive Aspergillosis

Werner J Heinz, MD, Oliver A Cornely, MD, Billy Franks, PhD, Fei Shi, PhD, Nkechi Azie, MD, Johan Maertens, MD

Blood (2014) 124 (21): 1133.

https://doi.org/10.1182/blood.V124.21.1133.1133

Published: 2014

Journal Articles

Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope™): Case Matched Analysis

Maria J.G.T. Vehreschild, MD, J. Janne Vehreschild, MD, Francisco M Marty, MD, John R Perfect, MD, Luis Ostrosky-Zeichner, MD, Galia Rahav, MD, Bernhardt Zeiher, MD, Misun Lee, PhD, Rochelle Maher, MD, Clint Lovell, MS, Marc Engelhardt, MD, Oliver A Cornely, MD

Blood (2014) 124 (21): 1151.

https://doi.org/10.1182/blood.V124.21.1151.1151

Published: 2014

Journal Articles

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Recipients: Results of the VOSIFI Study. on Behalf of the VOSIFI Study Group and the Infectious Diseases Working Party of the European Bone and Marrow Transplantation Group.

Catherine Cordonnier, MD, Hermann Einsele, MD, Montserrat Rovira, MD, Johan Maertens, Eduardo Olavarria, MD, Catherine Faucher, MD, Oliver A Cornely, MD, Rafael De La Camara, MD, Claus-Peter Heussel, MD, Marc Pineau, MD, Per T. Ljungman, MD, PhD

Blood (2008) 112 (11): 1159.

https://doi.org/10.1182/blood.V112.11.1159.1159

Published: 2008

Journal Articles

Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial).

Oliver A. Cornely, MD, Johan Maertens, MD, Mark Bresnik, MD, Raoul Herbrecht, MD

Blood (2005) 106 (11): 3222.

https://doi.org/10.1182/blood.V106.11.3222.3222

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A Phase III, Randomized, Double-Blind Trial to Evaluate Efficacy and Safety of Isavuconazole Versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Hematopoietic Stem Cell Transplant Patients with Invasive Aspergillosis

Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope™): Case Matched Analysis

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Recipients: Results of the VOSIFI Study. on Behalf of the VOSIFI Study Group and the Infectious Diseases Working Party of the European Bone and Marrow Transplantation Group.

Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial).

Email alerts

ASH Publications

American Society of Hematology

Update search

A Phase III, Randomized, Double-Blind Trial to Evaluate Efficacy and Safety of Isavuconazole Versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Hematopoietic Stem Cell Transplant Patients with Invasive Aspergillosis

Primary Treatment of Invasive Mucormycosis (IM) with Isavuconazole (VITAL Study) or Amphotericin Formulations (FungiScope™): Case Matched Analysis

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infection in Allogeneic Stem Cell Transplant Recipients: Results of the VOSIFI Study. on Behalf of the VOSIFI Study Group and the Infectious Diseases Working Party of the European Bone and Marrow Transplantation Group.

Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only